BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Cancer

Jaime De Leon
November 26, 2018 8:10 PM UTC

Patient sample, cell culture and mouse studies suggest miR-584-5p could help treat medulloblastoma. In patient tissue samples or tumor cells from patient-derived xenograft (PDX) mouse models of medull...

BCIQ Company Profiles

University of Texas Health Science Center

BCIQ Target Profiles

Eukaryotic translation initiation factor 4E family member 3 (eIF4E3)

Histone deacetylase 1 (HDAC1)

MicroRNA-584-5p (miR-584-5p)

BCIQ Company Profiles

University of Texas Health Science Center

BCIQ Target Profiles

Eukaryotic translation initiation factor 4E family member 3 (eIF4E3)

Histone deacetylase 1 (HDAC1)

MicroRNA-584-5p (miR-584-5p)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2026 BioCentury Inc. All Rights Reserved.
Copyright © 2026 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS